Patients who received a C.R. Bard G2 Retrievable IVC Filter may be at risk for serious and life-threatening complications due to fracture and migration of the device. Plaintiffs around the country have filed suit against Bard in order to obtain compensation for serious injuries and wrongful deaths allegedly related to the G2 filter.
The nationwide law firm of Bernstein Liebhard LLP is now reviewing personal injury claims related to the Bard G2 IVC filter. If you or a loved one suffered complications due to the fracture and/or migration of this device, please contact our Firm today at (888) 994-5118 to learn more about your available legal options.
C.R. Bard brought the G2 Retrievable IVC Filter to market in 2005, as replacement for another product called the Recovery IVC filter. The small, cage-like product is intended to be inserted into the inferior vena cava, where it “catches” blood clots that have traveled from the legs in order to prevent the formation of a pulmonary embolism in the lungs. IVC filters like the G2 and Recovery devices are indicated for patients who are at risk for blood clots, but either don’t respond well or can not tolerate treatment with anticoagulant medications.
Retrievable IVC filter are designed to be removed once a patient is no longer at risk for blood clots. When Bard launched the G2 filter in 2005, it claimed that new device offered greater resistance to migration and fracture, as well as, improved centering of the filter. The company also promised that these improvements would allow for extended time until retrieval of the filter was necessary.
Since 2010, the U.S. Food & Drug Administration (FDA) has issued two warning regarding possible complications associated with retrievable IVC filters, such as the Bard G2 device.
Two years before the FDA issued its second IVC filter communication, a study published in the Journal of Vascular and Interventional Radiology reported that the G2 filter was associated with a 12% rate of filter fracture. The same study also found that only 53.4% of a fractured filter’s struts (its spider-like legs) could be successfully removed from the body, as they had migrated to a position where retrieval was impossible.
In December 2015, NBC News aired an investigative report that raised serious questions about the safety and efficacy of the Bard G2 IVC filter series. Among other things, the investigation uncovered evidence indicating that, within a few months of its FDA approval, officials at Bard were concerned that G2 filters were more likely to fail than their competitors. The report also disclosed that the devices had been implicated in a dozen patient deaths. Read More
When an IVC filter fractures or migrates, patients may experience the following complications:
August 2015: Federally-filed Bard IVC filter lawsuits, including cases involving the G2 device, have been consolidated in the U.S. District Court, District of Arizona, for the purpose of coordinated pretrial proceedings. By December 2015, the litigation had grown to include more than 60 cases, with new filings being reported in courts around the U.S. Read More
Bernstein Liebhard LLP is now offering free, no-obligation legal reviews to anyone who suffered serious complications allegedly related to the Bard G2 IVC filter lawsuit. To learn whether or not your injuries might qualify for compensation, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.